• English
  • Sign In
  • Contact Us
Resources » Technical Resource Centers » Antibody Technical Resources » Antibody News » Stem Cell Secretome Leads to Somatic Cell Tumor Formation
Early stage embryo , Stem cell research , Morula


GenScript’s premier rabbit antibody generation service Perfect for high affinity mAb’s against difficult Ag’s

Stem Cell Secretome Leads to Somatic Cell Tumor Formation

October 16th, 2017

In order to identify why stem cell therapies result in metastatic tumors, researchers from the Medical University of Vienna analyzed the effect IPSC’s had on the invasiveness of neighboring fibroblasts. Using a transwell invasion assay, the results showed that stem cells have secretomes capable of turning on somatic cell invasion.

Specifically, the IPSC secretome activated IGF and mTORC1 in neighboring somatic cells. In the presence of matrix metalloproteinases, this signaling cascade also induced the invasion pathway normally used during tissue repair and development, leading to a teratoma. By inhibiting this pathway, researchers significantly reduced the size of stem cell induced teratomas, and gave hope that stem therapy could eventually be performed without fear of tumor formation.

Rosner, Margit et al. "Human stem cells alter the invasive properties of somatic cells via paracrine activation of mTORC1." Nature Communications 8 (2017).

Current Promotion!!